Recombinant metapneumovirus vaccine (Undisclosed novel adjuvant, Jiangsu Rec-Biotech)

重组偏肺病毒疫苗（未披露的新型佐剂，江苏瑞科生物）

Report date: 2025/12/11 09:55:46

Base Information

Drug NameRecombinant metapneumovirus vaccine (Undisclosed novel adjuvant, Jiangsu Rec-Biotech)

Drug Alias NameREC-627

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMetapneumovirus infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesJiangsu Rec-Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Rec-Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsMetapneumovirus infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A